These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2877850

  • 1. Pharmacological and biochemical actions of sulphasalazine.
    Hoult JR.
    Drugs; 1986; 32 Suppl 1():18-26. PubMed ID: 2877850
    [Abstract] [Full Text] [Related]

  • 2. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR, Moore PK.
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [Abstract] [Full Text] [Related]

  • 3. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA.
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacokinetics of sulphasalazine.
    Das KM, Dubin R.
    Clin Pharmacokinet; 1976 Nov; 1(6):406-25. PubMed ID: 15752
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U.
    Clin Pharmacokinet; 1985 Nov; 10(4):285-302. PubMed ID: 2864155
    [Abstract] [Full Text] [Related]

  • 6. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ, Neumann VC, Hill J, Astbury C, Le Gallez P, Dixon JS.
    Drugs; 1986 Nov; 32 Suppl 1():27-34. PubMed ID: 2877851
    [Abstract] [Full Text] [Related]

  • 7. Sulphasalazine: a review of 40 years' experience.
    Watkinson G.
    Drugs; 1986 Nov; 32 Suppl 1():1-11. PubMed ID: 2877847
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM, Bartholomew TC, Jewell DP.
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [Abstract] [Full Text] [Related]

  • 9. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
    Hillier K, Mason PJ, Pacheco S, Smith CL.
    Br J Pharmacol; 1982 May; 76(1):157-61. PubMed ID: 6123357
    [Abstract] [Full Text] [Related]

  • 10. Possible mode of action of 5-aminosalicylic acid.
    Peskar BM, Dreyling KW, May B, Schaarschmidt K, Goebell H.
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):51S-56S. PubMed ID: 2891468
    [Abstract] [Full Text] [Related]

  • 11. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H, Eisenburg J, Paumgartner G.
    Eur J Clin Pharmacol; 1984 Dec; 26(4):449-51. PubMed ID: 6428914
    [Abstract] [Full Text] [Related]

  • 12. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K, Hansen J, Bytzer P, Bukhave K, Rask-Madsen J.
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.
    Di Paolo MC, Paoluzi OA, Pica R, Iacopini F, Crispino P, Rivera M, Spera G, Paoluzi P.
    Dig Liver Dis; 2001 Oct; 33(7):563-9. PubMed ID: 11816545
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C, Taggart AJ, Juby L, Zebouni L, Bird HA.
    Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
    [Abstract] [Full Text] [Related]

  • 16. 5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.
    Clerici C, Gentili G, Pellicciari R, Gresele P, Mezzasoma AM, Giansanti M, Clementi M, Bartoli G, Balò S, Modesto R, Aburbeh AG, Morelli O, Morelli A.
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):385-90. PubMed ID: 9789134
    [Abstract] [Full Text] [Related]

  • 17. The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells.
    Punchard NA, Boswell DJ, Greenfield SM, Thompson RP.
    Biochem Pharmacol; 1992 Jun 09; 43(11):2369-76. PubMed ID: 1351726
    [Abstract] [Full Text] [Related]

  • 18. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1985 May 25; 290(6481):1535-8. PubMed ID: 2860942
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.
    Collier HO, Francis AA, McDonald-Gibson WJ, Saeed SA.
    Prostaglandins; 1976 Feb 25; 11(2):219-25. PubMed ID: 4854
    [Abstract] [Full Text] [Related]

  • 20. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Azad Khan AK, Piris J, Truelove SC.
    Lancet; 1977 Oct 29; 2(8044):892-5. PubMed ID: 72239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.